Olanzapine and quetiapine use during breastfeeding

Journal of Clinical Psychopharmacology

Volumn 35, Issue 2, 2015, Pages 206-208

  Aydin, Burc ^a   Nayir, Tugba ^b   Sahin, Selma ^c   Yildiz, Aysegul ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b ENV Engineering and Environmental Consulting   (Turkey)

^c EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE; QUETIAPINE; VALPROIC ACID; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADD ON THERAPY; ADULT; AREA UNDER THE CURVE; BIPOLAR DISORDER; BIRTH; BREAST FEEDING EDUCATION; BREAST MILK; CASE REPORT; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG USE; FEMALE; HUMAN; INFORMED CONSENT; LETTER; PRIORITY JOURNAL; SAFETY; BREAST FEEDING; METABOLISM; NEWBORN; TWINS;

ADULT; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; BENZODIAZEPINES; BIPOLAR DISORDER; BREAST FEEDING; FEMALE; HUMANS; INFANT, NEWBORN; MILK, HUMAN; QUETIAPINE FUMARATE; TWINS;

EID: 84924426403     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000291     Document Type: Letter

References (17)

1. Hoddinott P, Tappin D, Wright C. Breast feeding. BMJ. 2008;336:881-887.
2. Fortinguerra F, Clavenna A, Bonati M. Psychotropic drug use during breastfeeding: a review of the evidence. Pediatrics. 2009;124; e547-e556.
3. Klinger G, Stahl B, Fusar-Poli P, et al. Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev. 2013;10:308-317.
4. Gilad O, Merlob P, Stahl B, et al. Outcome of infants exposed to olanzapine during breastfeeding. Breastfeed Med. 2011;6:55-58.
5. Bennett PN. Use of the monographs on drugs. In: Bennett PN, ed. Drugs and Human Lactation. Amsterdam, the Netherlands: Elsevier; 1996:67-74.
6. Begg EJ, Duffull SB, Hackett LP, et al. Studying drugs in human milk: time to unify the approach. J Hum Lact. 2002;18:323-332.
7. Gentile S. Infant safety with antipsychotic therapy in breast-feeding: a systematic review. J Clin Psychiatry. 2008;69:666-673.
8. Brunner E, FalkDM, Jones M, et al. Olanzapine in pregnancy and breastfeeding: a review of data from global safety surveillance. BMC Pharmacol Toxicol. 2013;14:38.
9. Ambresin G, Berney P, Schulz P, et al. Olanzapine excretion into breast milk: a case report. J Clin Psychopharmacol. 2004;24:93-95.
10. Croke S, Buist A, Hackett LP, et al. Olanzapine excretion in human breast milk: estimation of infant exposure. Int J Neuropsychopharmacol. 2002;5:243-247.
11. Gardiner SJ, Kristensen JH, Begg EJ, et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am J Psychiatry. 2003; 160:1428-1431.
12. Stiegler A, Schaletzky R, Walter G, et al. Olanzapine treatment during pregnancy and breastfeeding: a chance for women with psychotic illness? Psychopharmacology (Berl). 2014;231:3067-3306.
13. Lutz UC,Wiatr G, Orlikowsky T, et al. Olanzapine treatment during breast feeding: a case report. Ther Drug Monit. 2008;30: 399-401.
14. Whitworth A, Stuppaeck C, Yazdi K, et al. Olanzapine and breast-feeding: changes of plasma concentrations of olanzapine in a breast-fed infant over a period of 5 months. J Psychopharmacol. 2010;24:121-123.
15. Misri S, Corral M, Wardrop AA, et al. Quetiapine augmentation in lactation: a series of case reports. J Clin Psychopharmacol. 2006;26:508-511.
16. Lee A, Giesbrecht E, Dunn E, et al. Excretion of quetiapine in breast milk. Am J Psychiatry. 2004;161:1715-1716.
17. Rampono J, Kristensen JH, Ilett KF, et al. Quetiapine and breast feeding. Ann Pharmacother. 2007;41:711-714.